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Abstract 
Background: A thinner cerebral cortex is associated with higher white matter hyperintensity 
(WMH) burden and cognitive impairment in community-dwelling and dementia cohorts. It is 
important to assess these associations in people with ischaemic stroke because their 
cerebrovascular disease profiles are different to these cohorts. 
 
Aims: We aimed to determine whether cortical thickness was related to WMH burden and 
cognition after ischaemic stroke. 
 
Methods: We measured cortical thickness using Advanced Normalisation Tools’ 
“KellyKapowski” function in 244 patients with ischaemic stroke or transient ischaemic attack 
from the Virtual International Stroke Trials Archive (VISTA). We measured WMH burden 
via quantitative volumes and Fazekas score. We extracted data on vascular risk factors at 
baseline and Mini Mental State Examination (MMSE) scores at one-year. We assessed 
associations between imaging and clinical data using correlations and multiple linear 
regression. 
 
Results: Pairwise correlation showed that higher WMH Fazekas score was associated with a 
thinner cortex (rho=-0.284, P<0.0001). WMH were generally distributed adjacent to and 
above the lateral ventricles. Voxel-wise analyses showed statistically significant negative 
associations between cortical thickness and WMH across fronto-temporal and inferior 
parietal cortical regions. Mean cortical thickness was positively related to MMSE in pair-
wise correlation (r=0.18, P=0.004) but there was no independent association after adjustment 
for age and WMH (beta=0.06, P=0.352). 
 
Conclusions: Cortical thickness was not an independent predictor of cognition after 
ischaemic stroke. Further work is required to understand how WMH are associated with a 
thinner cortex in temporal regions but less so in more superior regions where WMH are 
generally found in people with stroke.    
  
Introduction 
Brain atrophy and white matter hyperintensities (WMH) are common in people with 
ischaemic stroke and both are independently associated with worse outcome (1–3). Methods 
for measuring brain atrophy from magnetic resonance imaging (MRI) include assessment of 
grey and white matter volumes, cerebrospinal fluid volume, and more recently, cortical 
thickness (4,5). Cortical thickness is the distance between grey and white matter surfaces and 
measurement allows for voxel- or vertex-wise analyses across the cortex; potentially 
increasing sensitivity to detect associations with cognitive impairment (4,6–8). 
A thinner cortex is associated with higher WMH burden and lower cognition in community-
dwelling ageing, cognitively impaired, and small vessel disease (SVD) cohorts (7–11). These 
studies found associations between higher WMH burden and a thinner cortex in fronto-
temporal and inferior parietal regions. WMH are generally found adjacent to and above the 
lateral ventricles in ischaemic stroke and ageing cohorts, regions that underlie superior-
parietal/frontal and occipital lobes rather than temporal cortices (12,13). A longitudinal study 
of community-dwelling participants did not find a relationship between WMH progression 
and cortical thinning (14). We found no prior study to assess the relationship between WMH 
and cortical thickness, nor the association between cortical thickness and cognition, in people 
with ischaemic stroke. 
There is current considerable interest in identifying overall “cerebrovascular health” from 
MRI and whether this can predict cognitive impairment and dementia (3,15,16). These 
studies have shown that combined measures of atrophy and small vessel disease are more 
predictive of cognitive impairment than individual measures. It would be useful to quantify 
the predictive power of cortical thickness and whether it may add to burgeoning brain health 
measures in stroke.  
 
Aims 
We aimed to determine: 1) regions of the cortex negatively associated with WMH burden; 2) 
whether cortical thickness was predictive of cognition, as assessed by Mini-Mental State 
Examination (MMSE); and 3) whether WMH burden attenuated the association between 
cortical thickness and cognition in ischaemic stroke. 
 
Methods 
Participants and data extraction 
Brain MRI and clinical data were obtained from the Virtual International Stroke Trials Archive 
(VISTA) Prevention sub-archive (http://virtualtrialsarchives.org/vista). VISTA holds fully 
anonymised data from completed clinical trials, and had ethical approval for its procedures. 
Our project, to assess brain MRI markers in stroke, was approved by the VISTA steering 
committee. We extracted baseline brain MRI and vascular risk factors, and one-year follow-up 
Mini-Mental State Examination (MMSE) scores from VISTA where available. Vascular risk 
factors included reported diagnosis of hypertension, hypercholesterolemia, diabetes, smoking, 
atrial fibrillation and measured systolic and diastolic blood pressure. 
 
Brain MRI acquisition and processing 
Brain MRI was acquired at baseline and parameters are fully described in supplementary 
material. Intracranial volume (ICV), white matter hyperintensity (WMH) and normal-
appearing tissue volume processing was described previously (17); all processing outputs were 
checked and edited according to STRIVE  guidelines (18). Fazekas scores of WMH burden 
were assessed by a trained rater (FA) with FLAIR, or T2 if FLAIR was not available. FLAIR 
was not available for N=28 participants and this was required to measure WMH volumes. 
Therefore, we used Fazekas score as a measure of WMH burden in our main analyses. Stroke 
infarcts were manually masked by a trained image analyst consistent with STRIVE. Cortical 
thickness was measured across the cortex using the “KellyKapowski” function within 
Advanced Normalisation Tools (4,19). The distance to diffeomorphically register the white 
matter surface to grey matter surface is defined as cortical thickness in this tool. We calculated 
voxel-wise cortical thickness maps and mean cortical thickness for each participant. Mean 
cortical thickness is the mean of all voxel-wise measurements of cortical thickness within each 
subject. 
 
Statistical analyses 
All statistical analyses were performed using MatrixLaboratory (MATLAB) R2017b (© 
1994-2018 The MathWorks, Inc.). We assessed pair-wise correlations between mean cortical 
thickness, WMH, vascular risk factors, and MMSE using Pearson and Spearman correlations. 
We used multiple linear regression with standardised beta to assess whether statistically 
significant pair-wise associations with mean cortical thickness and MMSE remained 
significant in adjusted co-variate models including age and WMH. Statistical normality of 
variables and regression residuals was assessed by visual interpretation of histogram plots. 
Heteroscedasticity and non-linearity were assessed via residual versus predicted value plots. 
Multicollinearity was assessed via the variance inflation factor. 
 
Voxel-wise cortical thickness analyses 
Voxel-wise multiple linear regression models were performed - to assess which regions of the 
cortex were associated with WMH burden and MMSE - using cortical thickness maps. At 
each voxel across the cortex we tested the association between cortical thickness, WMH 
burden, and MMSE. We ran these models with and without adjustment for co-variates. We 
corrected for multiple comparisons in voxel-wise analyses using false discovery rate with 
critical value 0.05 (20). 
 
 
 
  
Results 
Participant characteristics 
Of N=454 participants in the VISTA Prevention sub-archive who had brain MRI, N=158 did 
not have a useable T1 MRI and an additional N=52 had missing clinical, demographic and/or 
cognitive data. This left N=244 participants that were included in our analyses. Participants 
were not excluded for any other reason than missing data. Full characteristics of the N=244 
included participants are provided in table 1. Briefly, mean age was 66 years, 66% were 
male, median Fazekas score was 2, mean WMH volume was approximately 13ml, mean 
cortical thickness was 3.27mm, and mean MMSE was 26. WMH volumes were generally 
distributed adjacent to and above the lateral ventricles (figure 1). WMH volume and Fazekas 
score were highly correlated (rho=0.884, P<0.0001). WMH burden was quantified via 
Fazekas score in all remaining analyses. 
 
Pairwise associations with mean cortical thickness 
Pairwise associations with mean cortical thickness are in table 2. A thinner cortex was 
associated with older age, female sex, higher WMH burden, lower ICV, higher blood 
pressure, and lower MMSE. 
 
Prediction of MMSE by cortical thickness after adjustment 
Mean cortical thickness was no longer significantly predictive of MMSE after adjustment for 
age and WMH Fazekas score (table 3). Voxel-wise models showed that a thinner cortex in 
fronto-temporal and inferior parietal regions was associated with lower MMSE but this was 
greatly attenuated after adjustment for age, sex, ICV, and vascular risk factors. Following 
inclusion of Fazekas score in the adjusted model there was no significant relationship 
between cortical thickness across the cortex and MMSE (figure 2). There was evidence for 
non-normality of residuals, non-linearity, and heteroscedasticity in these models. Variance 
inflation factor was low, between 1.05 and 1.26.   
 
 
Adjusted associations between cortical thickness and WMH burden 
Higher WMH burden was associated with a thinner cortex in fronto-temporal and inferior 
parietal regions, the extent of these associations was attenuated but remained intact after 
adjustment for age, sex, ICV, and vascular risk factors (figure 3). There was limited evidence 
for non-normality of residuals, non-linearity, and heteroscedasticity between WMH burden 
and cortical thickness; variance inflation factor was low (between 1.04 and 1.98).    
 
Although data are not shown here, we repeated all main analyses in the subset of participants 
with useable FLAIR MRI, substituting WMH volume for Fazekas score, and results were 
broadly similar. 
 
Discussion 
We have shown that higher WMH burden is associated with a thinner cortex in fronto-
temporal and inferior parietal regions in ischaemic stroke. These associations remained after 
adjustment for age, sex, head size and vascular risk factors. This pattern of association across 
fronto-temporal and inferior parietal regions is similar to those found in community-dwelling 
ageing, cognitively impaired, and SVD cohorts (10,14,21). We found that a thinner cortex in 
these regions and lower mean (overall) cortical thickness was associated with lower one-year 
follow-up MMSE score in pairwise analyses. However, these associations were attenuated to 
non-statistical significance after adjustment for age, sex, head size, vascular risk factors, and 
WMH. This is unlike ageing and cognitive impairment studies that found cortical thickness to 
be predictive of cognition, even after adjustment for co-variates (8,11,16). 
The negative associations we found between WMH burden and cortical thickness were in 
very similar regions to those in ageing and dementia studies (10,14,21). Temporal cortical 
regions do not directly overlie the general distribution of WMH in ageing and ischaemic 
stroke cohorts; which commonly extends adjacent to and above the lateral ventricles (12,13). 
Additionally, previous work has shown that progression of WMH and cortical thinning were 
not related in a longitudinal study of community-dwelling participants (14). It should be 
noted however that the associations we found here are cross-sectional and further work is 
required to understand the mechanism(s) of WMH progression and cortical thinning. Whether 
or not there is a causal relationship between increasing WMH burden and cortical thinning in 
stroke can only be answered in a longitudinal study. Stroke patients have a higher burden of 
WMH than community-dwelling participants (22) and this may allow for any longitudinal 
relationship to be identified. 
There was no statistically significant association between mean cortical thickness and MMSE 
when we included WMH burden (Fazekas score) into our models. The higher burden of 
WMH in stroke patients (22) may explain why the association between WMH and cognition 
was demonstrable but that between cortical thickness and cognition was not. Whole brain 
cerebrospinal fluid volume, which includes ventricular expansion not captured by cortical 
thickness, may be a more useful marker of brain atrophy in stroke (3). 
Our study has limitations. Although we had a relatively large sample of participants, larger 
samples may be required to reveal adjusted associations between cortical thickness and 
cognition in stroke. Our results are cross-sectional and future work in longitudinal studies is 
required to determine if there is a causal relationship between WMH progression and cortical 
thinning in stroke. As we used data from clinical trials with MRI our results may not be 
generalised to people not well or motivated enough to take part in trials or tolerate MRI. 
Additionally, there was large variation in time from stroke to inclusion in each contributing 
study and we did not have data on whether or not participants had stroke prior to inclusion, 
i.e., whether their stroke event for inclusion in a contributing study was recurrent. We did not 
assess associations between stroke infarct volume and cortical thickness as this has been done 
previously (23). Neither MMSE, WMH volume, nor Fazekas score were distributed 
statistically normal and this could have led to a violation of the assumptions of our 
parametric-based regression analyses. However, there was limited evidence for non-
normality of residuals, heteroscedasticity and non-linearity in the WMH models and, as 
shown in table 2, parametric- and nonparametric-based analyses generally showed very 
similar results. This is except for the parametric (that showed statistical significance) and 
non-parametric (that did not show statistical significance) correlations between MMSE and 
cortical thickness. There was evidence for heteroscedasticity, non-linearity, and non-
normality of residuals in the MMSE and cortical thickness models and this likely explains 
these differing results. However, accepting the nonparametric result would only underline our 
conclusion that cortical thickness has limited utility for predicting cognition in stroke. Future 
work may assess potential non-linear relationships between MMSE and cortical thickness. 
We had a limited battery of vascular risk factors but included those which have been shown 
to contribute to most of the population attributable risk of stroke (24). Brain MRI were 
acquired at several different centres with differing image acquisition parameters, including 
non-isometric T1 scans. This may have limited our ability to accurately measure cortical 
thickness. However, this at least shows that stroke imaging studies should consistently 
acquire high resolution isometric T1 images for cortical thickness to be useful. MMSE is a 
crude measure of global cognitive function but it has been shown that MMSE is a reasonable 
and quick tool to detect cognitive impairment in stroke survivors (25). Future work is needed 
to assess associations between cortical thickness and specific cognitive domains, e.g., as 
assessed by Montreal Cognitive Assessment (MoCA), which may be stronger than the 
associations between cortical thickness and global cognitive function reported here. Finally, 
we did not have assessments of cognition prior to stroke, e.g., years of education, therefore 
could not adjust for premorbid cognitive ability which has been shown to be a strong 
predictor of post-stroke cognition (26). 
Notwithstanding these limitations, our study provides data on the relationships between 
cortical thickness, WMH, and cognition in ischaemic stroke. Unlike in ageing and dementia 
cohorts, a thinner cortex may not be an independent predictor of cognitive impairment in 
ischaemic stroke. Further work is required to understand how WMH are associated with a 
thinner cortex in temporal regions but less so in more superior regions where WMH are 
generally found in people with stroke. 
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Table 1. Participant characteristics 
Age 65.5±12.3 (median=67, range=22.6-89.5) years 
Sex Male=161 (66%) 
Female=83 (34%) 
Fazekas score Median=2, IQR=3 
White matter hyperintensities volume 12.5±12.6ml (median=8ml, IQR=15ml) 
Mean cortical thickness 3.27±0.20mm 
Intracranial volume 1331.7±137.0ml 
Current smoking N=55 (22.5%) 
Past smoking N=72 (29.5%) 
Hypertension N=184 (75.4%) 
Hypercholesterolaemia N=128 (52.5%) 
Atrial fibrillation N=9 (3.7%) 
Death during study N=22 (9.0%) 
Systolic blood pressure 140±29mm/Hg 
Diastolic blood pressure 81±16mm/Hg 
Diabetes N=70 (28.7%) 
Mini Mental State Examination 25.5±5.2 (median=28, IQR=6) 
Transient ischaemic attack N=47 (19.3%) 
Time from stoke to baseline assessment 67.1±61.4 (range=0-328) days 
Note: IQR=interquartile range. 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 2. Pair-wise correlations with cortical thickness 
Parameter Pearson Spearman 
Age r=-0.243, P<0.0001* rho=-0.194, P=0.0023* 
Male sex r=0.154, P=0.0161* rho=0.150, P=0.0189* 
White matter hyperintensities Fazekas 
score 
r=-0.299, P<0.0001* rho=-0.284, P<0.0001* 
Intracranial volume r=0.398, P<0.0001* rho=0.345, P<0.0001* 
Current smoking r=-0.014, P=0.8324 rho=-0.010, P=0.8822 
Past smoking r=-0.002, P=0.9705 rho=0.000, P=0.9984 
Hypertension r=-0.124, P=0.0528 rho=-0.105, P=0.1032 
Hypercholesterolaemia r=-0.010, P=0.8793 rho=0.017, P=0.7929 
Atrial fibrillation r=0.011, P=0.8685 rho=0.030, P=0.6433 
Death during study r=0.016, P=0.8041 rho=-0.013, P=0.8423 
Systolic blood pressure r=-0.188, P=0.0032* rho=-0.132, P=0.0391* 
Diastolic blood pressure r=-0.130, P=0.0430* rho=-0.045, P=0.4854 
Diabetes r=-0.022, P=0.7311 rho=0.000, P=0.9904 
Mini Mental State Examination r=0.167, P=0.0088* rho=0.094, P=0.1437 
Note: *P<0.05. 
 
 
 
 
 
 
 
 
 
  
Table 3. Multiple linear regression adjusted associations between mean cortical thickness and 
MMSE 
Model Mean cortical 
thickness beta 
Age beta WMH beta 
MMSE ~ MCT 0.167±0.063 
(P=0.0088)*     
N/A N/A 
MMSE ~ MCT + Age 0.064±0.059 
(P=0.2854)     
-0.428±0.059 
(P<0.0001)* 
N/A 
MMSE ~ MCT + 
WMH 
0.051±0.062 
(P=0.4060) 
N/A -0.388±0.062 
(P<0.0001)*       
MMSE ~ MCT + Age 
+ WMH 
0.016±0.059 
(P=0.7874) 
-0.323±0.064 
(P<0.0001)* 
-0.244±0.065 
(P=0.0002)* 
Note: MMSE was the dependent variable and cortical thickness, age and WMH were 
independent variables; Standard error for beta are shown after ±; MCT=mean cortical 
thickness; WMH=white matter hyperintensities measured by Fazekas scale; MMSE= Mini 
Mental State Examination; *P<0.05. 
 
 
 
 
 
 
  
Figure 1. White matter hyperintensity (WMH) volume distribution map. WMH were most 
commonly found adjacent to and above the lateral ventricles (red≥50%) and were less 
frequently found in anterior frontal, inferior parietal and temporal regions (blue to 
purple≤10%).  
 
 
 
 
  
Figure 2. Associations between baseline cortical thickness and one-year follow-up Mini-
Mental State Examination (MMSE) score across the cortex. Regions in red/yellow show 
where there were statistically significant associations between higher MMSE score and a 
thicker cortex. Yellow regions have the lowest false discovery rate (FDR) corrected P-values 
(P≥0.001) towards red regions with the highest FDR corrected, statistically significant P-
values (P<0.05). Grey regions show no statistically significant association. The top panel 
shows unadjusted pairwise associations between MMSE and cortical thickness, the middle 
panel shows associations adjusted for intracranial volume (ICV), age, sex, and vascular risk 
factors, and the bottom panel shows adjustment with ICV, age, sex, vascular risk factors, and 
white matter hyperintensity (WMH) Fazekas score (no voxel-wise associations survived 
adjustment). 
 
 
 
 
 
 
 
  
Figure 3. Associations between white matter hyperintensity (WMH) Fazekas score and 
cortical thickness across the cortex. Regions in red/yellow show where there were statistically 
significant associations between higher WMH score and a thinner cortex. Yellow regions 
have the lowest false discovery rate (FDR) corrected P-values (P≥0.001) towards red regions 
with the highest FDR corrected, statistically significant P-values (P<0.05). Grey regions 
show no statistically significant association. The top panel shows unadjusted pairwise 
associations between WMH and cortical thickness and the bottom panel shows associations 
adjusted for intracranial volume (ICV), age, sex, and vascular risk factors.  
